The ExPERT STx electroporation technology is capable of high-performance delivery of virtually any molecule, into any cell, at any scale with the unique ability to transfect primary cells, stem cells and cell lines with minimal disturbance resulting in transfection efficiencies routinely ≥90%.
The industry’s leading scalable electroporation technology for high-yield, transient expression of complex proteins, vaccines and biologics
- Rapidly transfect up to 20 billion cells
- Proprietary Flow Electroporation® technology
- Closed, cGMP-compliant system, 21 CFR part 11 compliant, ISO-certified and CE-marked
- Improved yields, at scale, can decrease development timelines and, paired with flexible media strategies, deliver significant cost savings
- Faster production of stable clones
- Ideal for large-scale cell therapy optimization, training, process development and feasibility studies from early product development to pre-IND validation studies